Antiemetics And Antinauseants Industry Forecasted for Rapid Expansion, Reaching $10.01 Billion by 2030


 The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided.

What Is the Current Market Size and Growth Rate of the Antiepileptic Drugs Market?
The antiemetics and antinauseants market size has grown steadily in recent years. It will grow from $8.48 billion in 2025 to $8.72 billion in 2026 at a compound annual growth rate (CAGR) of 2.8%. The growth in the historic period can be attributed to increasing cancer incidence, growth in surgical procedures, rising awareness of chemotherapy side effects, expansion of hospital and clinic infrastructure, advances in antiemetic drug formulations.

The antiemetics and antinauseants market size is expected to see steady growth in the next few years. It will grow to $10.01 billion in 2030 at a compound annual growth rate (CAGR) of 3.5%. The growth in the forecast period can be attributed to increasing prevalence of motion sickness, growth in global geriatric population, rising adoption of personalized medicine, innovations in novel antiemetic drug delivery systems, expansion of outpatient chemotherapy and palliative care services. Major trends in the forecast period include personalized anti-nausea therapy development, novel drug delivery systems, combination therapy approaches, rising demand for chemotherapy supportive care, growth in motion sickness and travel-related treatments.

Claim your free report sample now:
https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report

What Are the Major Drivers Influencing the Antiemetics And Antinauseants Market?
Increased prevalence of tuberculosis is expected to propel the growth of antiemetics and antinauseants market. Tuberculosis (TB) is an infectious bacterial disease primarily impacting the lungs. Antiemetics and antinauseants are employed for the purpose of controlling nausea and vomiting induced by anti-tuberculosis medications. For instance, in March 2025, according to the Centers for Disease Control and Prevention, a US-based federal agency, in 2024, a provisional total of 10,347 tuberculosis cases were reported in the United States, corresponding to a rate of 3.0 cases per 100,000 population an increase of approximately 8% compared with 2023. Therefore, the increased prevalence of tuberculosis is expected to propel the growth of antiemetics and antinauseants market.

What Segment Categories Define the Antiemetics And Antinauseants Market Structure?
The antiemetics and antinauseants market covered in this report is segmented –

1) By Drug: Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 receptor antagonists, Other Drug Types
2) By Application: Chemotherapy, Motion sickness, Gastroenteritis, General anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Other Application Types
3) By End Users: Hospital, Medical Center, Clinic, Research Institutes

Subsegments:
1) By Dopamine Antagonists: Metoclopramide, Prochlorperazine, Domperidone
2) By NK1 Receptor Antagonists: Aprepitant, Fosaprepitant, Rolapitant
3) By Antihistamines (H1 Histamine Receptor Antagonists): Dimenhydrinate, Meclizine, Diphenhydramine
4) By Cannabinoids: Dronabinol, Nabilone
5) By Benzodiazepines: Lorazepam, Diazepam
6) By Anticholinergics: Scopolamine, Glycopyrrolate
7) By Steroids: Dexamethasone, Methylprednisolone
8) By 5-HT3 Receptor Antagonists: Ondansetron, Granisetron, Palonosetron
9) By Other Drug Types: Herbal Remedies, Acupressure Devices

How Are Current Trends Influencing the Antiemetics And Antinauseants Market Growth?
Major companies operating in the antiemetic and antinauseant markets are working on new product innovations, such as ready-to-use injectables, to streamline treatment processes and enhance patient compliance. These ready-to-use formulations are designed to provide immediate effectiveness, reducing the time and complexity associated with traditional injectable medications. For instance, in July 2024, Amneal Pharmaceuticals, a US-based pharmaceutical company, launched FOCINVEZ, the first ready-to-use injectable formulation of fosaprepitant, designed to prevent acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy. This product is available in a 150 mg/50 mL vial, free of Polysorbate 80, and does not require reconstitution or dilution, allowing for direct administration. FOCINVEZ is approved for use in adults and pediatric patients aged six months and older and has been assigned a unique J-Code (J1434) for reimbursement.

Which Are the Top Companies in the Antiemetics And Antinauseants Market?
Major companies operating in the antiemetics and antinauseants market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Cipla Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Kyowa Hakko Kirin Pharma Co. Ltd., Daiichi Sankyo Company, Braun GmbH, Eisai Co. Ltd., Sun Pharmaceuticals Industries Ltd., Dr. Reddy's Laboratories, Hikma Pharmaceuticals plc, IPCA Laboratories Ltd., Eagle Pharmaceuticals Inc., Cadila Pharmaceuticals Ltd., Bristol Laboratories Ltd., Tesaro Inc., SRS Pharmaceuticals Pvt. Ltd., Acacia Pharma Ltd., Algen Healthcare Ltd., Mirabilia Sciences Pvt. Ltd., Helsinn Healthcare SA

Get the full antiemetics and antinauseants market report here:
https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report

How does the Antiemetics And Antinauseants Market perform across different regions?
North America was the largest region in the drugs for antiemetics and antinauseants market in 2025. The Middle East is expected to be the fastest-growing region in the global antiemetics and antinauseants market share. The regions covered in the antiemetics and antinauseants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company: Global Market Research Reports & Consulting | The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: The Business Research Company | LinkedIn

Comments

Popular posts from this blog

Train And Components Market Report 2025 – Strategic Data for Growth and Expansion

Construction Market Outlook 2025 – In-Depth Data for Business Expansion to 2034

Global Fire Retardant Welding Blanket Market Report 2025: Market Opportunities & Challenges Outlook